Rickard Ericsson - Vitrolife Vice President Market Region EMEA & Americas
VITR Stock | SEK 224.80 1.20 0.53% |
President
Mr. Rickard Ericsson has served as Chief Sales Marketing Officer at Vitrolife AB since 2017. He has previously been Vice President Market Region EMEA Americas at Vitrolife AB since 2015. He holds M.Sc. in Industrial Engineering and Management. He previously was Business Development Director Europe at SCA Incontinence Care, Sales and Marketing Director UK Ireland at SCA Incontinence Care, Management Consultant at Adera and Business Development Manager Key Account Manager at Telia. since 2017.
Age | 52 |
Tenure | 7 years |
Phone | 46 3 17 21 80 00 |
Web | https://www.vitrolife.com |
Vitrolife Management Efficiency
The company has return on total asset (ROA) of 0.0205 % which means that it generated a profit of $0.0205 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0246 %, meaning that it generated $0.0246 on every $100 dollars invested by stockholders. Vitrolife's management efficiency ratios could be used to measure how well Vitrolife manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Found 4 records | PRESIDENT Age | ||
Jan Larsen | Invisio Communications AB | 61 | |
Sigge Frolov | Invisio Communications AB | 60 | |
Carsten Aagesen | Invisio Communications AB | 55 | |
Joakim Birgersson | Invisio Communications AB | 59 |
Management Performance
Return On Equity | 0.0246 | |||
Return On Asset | 0.0205 |
Vitrolife AB Leadership Team
Elected by the shareholders, the Vitrolife's board of directors comprises two types of representatives: Vitrolife inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vitrolife. The board's role is to monitor Vitrolife's management team and ensure that shareholders' interests are well served. Vitrolife's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vitrolife's outside directors are responsible for providing unbiased perspectives on the board's policies.
Rickard Ericsson, Vice President Market Region EMEA & Americas | ||
Daniel Forss, VP Consumables | ||
Claus Bisgaard, VP Technologies | ||
Ricardo Capella, VP Services | ||
Karin Russberg, VP Sustainability | ||
Patrik Tolf, Chief Officer | ||
Thomas MSc, Pres CEO |
Vitrolife Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Vitrolife a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0246 | |||
Return On Asset | 0.0205 | |||
Profit Margin | 0.12 % | |||
Operating Margin | 0.20 % | |||
Current Valuation | 28.19 B | |||
Shares Outstanding | 135.45 M | |||
Shares Owned By Insiders | 32.02 % | |||
Shares Owned By Institutions | 43.80 % | |||
Price To Earning | 58.44 X | |||
Price To Book | 1.61 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Vitrolife Stock Analysis
When running Vitrolife's price analysis, check to measure Vitrolife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vitrolife is operating at the current time. Most of Vitrolife's value examination focuses on studying past and present price action to predict the probability of Vitrolife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vitrolife's price. Additionally, you may evaluate how the addition of Vitrolife to your portfolios can decrease your overall portfolio volatility.